Key result
Administration of glucose-insulin-potassium (GIK) reduced stress-induced myocardial ischemia from 19% to 7% of the ventricular mass and prevented postoperative myocardial injury during spinal surgery.
Why the study?
Glucose-insulin-potassium (GIK) has demonstrated cardioprotective effects in cardiac surgery, but its use during non-cardiac surgery in patients with ischemic heart disease had not been clinically reported.
Does glucose-insulin-potassium (GIK) infusion prevent myocardial ischemia and injury in a patient with severe ischemic heart disease undergoing non-cardiac surgery?
Case Report (n=1)
No
Does glucose-insulin-potassium (GIK) infusion prevent myocardial ischemia and injury in a patient with severe ischemic heart disease undergoing non-cardiac surgery?
Absolute Event Rate: 7% vs 19%
GIK infusion may offer cardioprotection during non-cardiac surgery in patients with severe, non-revascularizable ischemic heart disease.
GIK may offer perioperative cardioprotection in severe IHD; hypothesis-generating and requires RCTs before any practice consideration.
The administration of glucose-insulin-potassium (GIK) has demonstrated cardioprotective effects in cardiac surgery. A 58-year-old male with severe disabling back pain due to posterolateral lumbar pseudarthrosis was scheduled for spine surgery. He previously experienced two episodes of acute coronary syndrome that required percutaneous coronary interventions (PCIs). Coronary angiogram showed intrastent occlusions and multiple coronary lesions that were not suitable for percutaneous or surgical revascularization. During pharmacological stress imaging, myocardial ischemia developed in 19% of the ventricular mass and was reduced to 7% when GIK was administered. After anesthesia induction, the GIK solution was also infused and surgery was uneventful, with no signs of postoperative myocardial injury. Four days later, the patient was successfully discharged to a rehabilitation center. This is the first clinical report of GIK pretreatment during non-cardiac surgery in a patient with ischemic heart disease (IHD).
No takes yet. Share an insight, caveat, or question.
Tesoro et al. (2022) conducted a case report in Stress-induced myocardial ischemia (n=1). Glucose-insulin-potassium (GIK) vs. Baseline (no GIK) was evaluated on Myocardial ischemia extent on PET-CT. Administration of glucose-insulin-potassium (GIK) reduced stress-induced myocardial ischemia from 19% to 7% of the ventricular mass and prevented postoperative myocardial injury during spinal surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: